These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 36203545)

  • 21. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
    Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.
    Wilamowski M; Hammel M; Leite W; Zhang Q; Kim Y; Weiss KL; Jedrzejczak R; Rosenberg DJ; Fan Y; Wower J; Bierma JC; Sarker AH; Tsutakawa SE; Pingali SV; O'Neill HM; Joachimiak A; Hura GL
    Biophys J; 2021 Aug; 120(15):3152-3165. PubMed ID: 34197805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
    Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia.
    Obeid DA; Alsanea MS; Alnemari RT; Al-Qahtani AA; Althawadi SI; Mutabagani MS; Almaghrabi RS; Alhadheq FM; Alahideb BM; Alhamlan FS
    J Infect Dev Ctries; 2021 Dec; 15(12):1782-1791. PubMed ID: 35044933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors.
    Kirchdoerfer RN; Ward AB
    Nat Commun; 2019 May; 10(1):2342. PubMed ID: 31138817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric activation of SARS-CoV-2 RdRp by remdesivir triphosphate and other phosphorylated nucleotides.
    Wang B; Svetlov V; Wolf YI; Koonin EV; Nudler E; Artsimovitch I
    bioRxiv; 2021 Apr; ():. PubMed ID: 33948598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex.
    Chen J; Malone B; Llewellyn E; Grasso M; Shelton PMM; Olinares PDB; Maruthi K; Eng E; Vatandaslar H; Chait BT; Kapoor T; Darst SA; Campbell EA
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
    Baddock HT; Brolih S; Yosaatmadja Y; Ratnaweera M; Bielinski M; Swift LP; Cruz-Migoni A; Fan H; Keown JR; Walker AP; Morris GM; Grimes JM; Fodor E; Schofield CJ; Gileadi O; McHugh PJ
    Nucleic Acids Res; 2022 Feb; 50(3):1484-1500. PubMed ID: 35037045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Architecture of a SARS-CoV-2 mini replication and transcription complex.
    Yan L; Zhang Y; Ge J; Zheng L; Gao Y; Wang T; Jia Z; Wang H; Huang Y; Li M; Wang Q; Rao Z; Lou Z
    Nat Commun; 2020 Nov; 11(1):5874. PubMed ID: 33208736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.
    Alosaimi B; Naeem A; Alghoribi MF; Okdah L; Hamed ME; AlYami AS; Alotaibi A; Enani M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2.
    Mishra A; Rathore AS
    J Biomol Struct Dyn; 2022 Aug; 40(13):6039-6051. PubMed ID: 33491569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2.
    Kumar D T; Shaikh N; Kumar S U; Doss C GP; Zayed H
    Front Mol Biosci; 2021; 8():645216. PubMed ID: 33898520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.
    Chand GB; Banerjee A; Azad GK
    PeerJ; 2020; 8():e9492. PubMed ID: 32685291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Simple
    Lu G; Zhang X; Zheng W; Sun J; Hua L; Xu L; Chu XJ; Ding S; Xiong W
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of replicating SARS-CoV-2 polymerase.
    Hillen HS; Kokic G; Farnung L; Dienemann C; Tegunov D; Cramer P
    Nature; 2020 Aug; 584(7819):154-156. PubMed ID: 32438371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.